588 related articles for article (PubMed ID: 36065731)
1. Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.
Torumkuney D; Kundu S; Vu GV; Nguyen HA; Pham HV; Kamble P; Truong Ha Lan N; Keles N
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i26-i34. PubMed ID: 36065731
[TBL] [Abstract][Full Text] [Related]
2. Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Kozlov R; Sidorenko S; Kamble P; Lezhnina M; Galushkin A; Kundu S
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i61-i69. PubMed ID: 36065732
[TBL] [Abstract][Full Text] [Related]
3. Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Nijhara P; Beltrame CO; Baisch EQ; Ferreira RM
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i35-i42. PubMed ID: 36065730
[TBL] [Abstract][Full Text] [Related]
4. Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Jamil B; Nizamuddin S; van Hasselt J; Pirzada U; Manenzhe R
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i18-i25. PubMed ID: 36065729
[TBL] [Abstract][Full Text] [Related]
5. Country data on AMR in Mexico in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; de la Torre C; Langfeld K; Lopez-Turrent NP; Ossaille Beltrame C
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i43-i50. PubMed ID: 36065728
[TBL] [Abstract][Full Text] [Related]
6. Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Poojary A; Shenoy B; Nijhara P; Dalal K; Manenzhe R
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i10-i17. PubMed ID: 36065726
[TBL] [Abstract][Full Text] [Related]
7. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Aktas Z; Unal S; van Hasselt J; Seyhun Y; Keles N
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i51-i60. PubMed ID: 36065733
[TBL] [Abstract][Full Text] [Related]
8. Country data on AMR in Kuwait in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Behbehani N; van Hasselt J; Hamouda M; Keles N
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i77-i83. PubMed ID: 36065725
[TBL] [Abstract][Full Text] [Related]
9. Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
Torumkuney D; Dolgum S; van Hasselt J; Abdullah W; Keles N
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i70-i76. PubMed ID: 36065727
[TBL] [Abstract][Full Text] [Related]
10. Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022.
Cantón R; Akova M; Langfeld K; Torumkuney D
J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i2-i9. PubMed ID: 36065724
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
[TBL] [Abstract][Full Text] [Related]
12. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA
PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
Gordon KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H
Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections.
Felmingham D; Feldman C; Hryniewicz W; Klugman K; Kohno S; Low DE; Mendes C; Rodloff AC
Clin Microbiol Infect; 2002; 8 Suppl 2():12-42. PubMed ID: 12427206
[TBL] [Abstract][Full Text] [Related]
17. Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
Torumkuney D; Van PH; Thinh LQ; Koo SH; Tan SH; Lim PQ; Sivhour C; Lamleav L; Somary N; Sosorphea S; Lagamayo E; Morrissey I
J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i19-i42. PubMed ID: 32337597
[TBL] [Abstract][Full Text] [Related]
18. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.
Van PH; Binh PT; Minh NH; Morrissey I; Torumkuney D
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i93-102. PubMed ID: 27048586
[TBL] [Abstract][Full Text] [Related]
19. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections.
Ehrhardt AF; Russo R
Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441
[TBL] [Abstract][Full Text] [Related]
20. Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.
Torumkuney D; Gur D; Soyletir G; Gurler N; Aktas Z; Sener B; Tunger A; Bayramoglu G; Koksal I; Yalcin AN; Tanriver Y; Morrissey I; Barker K
J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i85-91. PubMed ID: 27048585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
